Number of Nations Logging onto PFS Foundation Website Rises

General Discussion Media & Awareness
#1

pfsfoundation.org/news/natio … s-22-2014/

Finasteride Syndrome Foundation Website Rises 22% in 2014
Overall Traffic Jumps 64% vs. 2013

SOMERSET, N.J., Jan. 6, 2015 – The number of nations that logged onto the Post-Finasteride Syndrome Foundation website jumped 22 percent in 2014, according to Google Analytics.

In all, users in 157 countries—or 81 percent of the world (as defined by the 195 nations recognized by the U.S. Department of State)—accessed information on the condition via PFSFoundation.org, versus 129 countries during the period from the website’s launch in August 2012 through 2013.

Visits from outside the U.S. comprised 54 percent of the site’s total annual traffic in 2014.

Additionally, the total number of unique visitors to the site rose 64 percent in 2014 compared to 2013.

Separately, between June 2009 and June 2014, via its MedWatch program, the U.S. Food and Drug Administration received reports of adverse finasteride events from patients and health care professionals in 33 nations outside the U.S., including the U.K., Japan, France, Germany, Canada, Denmark, China, Italy, Spain and Israel.

PFS has been reported to occur in men who have taken the prescription drug finasteride to treat hair loss (under the brand name Propecia and generics), or enlarged prostates (Proscar and generics).

Reported symptoms include loss of libido, erectile dysfunction, depression, suicidal ideation, anxiety, panic attacks, Peyronie’s disease, penile shrinkage, gynecomastia, muscle atrophy, cognitive impairment, insomnia, severely dry skin, and tinnitus. The condition often has a life-altering impact on victims and their families, such as job loss and the breakup of marriages and romantic relationships, while also being linked to suicides.

“At this current rate of expanding awareness, we’re likely to see users from most every nation on earth educating themselves on PFS before the decade is out,” said PFS Foundation CEO Dr. John Santmann.

#2

Keep spreading the word everyone!

#3

Interesting that the FDA has received adverse-reaction reports about finasteride from so many countries. I didn’t even know the FDA accepted such reports from outside the US.

I wonder if other health agencies abroad are also getting adverse-reaction reports about finasteride.

Someone should start asking.

#4

As the FDA is receiving reports from so many countries, what are they waiting to mandate consent forms as a condition to prescribe Propecia? Ok, you don´t have a study yet that fully explains how PFS develops, but the adverse complaints are more than enough to do something. Is the doctor has a legal obligation to present the consent form for the patient to sign, we will at least end the cases in which the doctor does not mention the possibility of serious side effects. If FDA does not have political power to withdraw propecia now, at least start the consent form obligation. Right now. Can the PFS foundation request such thing from the FDA?

#5

The foundation has no power for having the FDA make any changes to Propecia or it’s removal from the market. Back in 2012, a Doctor that I have spoken to was single handedly responsible for the label changes but this took months of persistence. Thank god for this Doctor I say

The FDA are dysfunctional. They are in bed with Merck. Both scratch each other’s backs

Propecia will NEVER be taken off the market, not even after the 3 studies are published because then Merck and the FDA are fully liable. Both FDA and Merck know the full extent of our situation but choose to do nothing about it by burying their heads in the sands

#6

All true, TH. Sad but true.